Evidence map›Paper›PMID 41167701›Full record

ArticleIn vivo (Athens, Greece)

O-Linked N-Acetylglucosamine Epitope H Expression in Placentas of Pregnancies Complicated With Fetal Growth Restriction: A Case-Control Immunochemistry Study.

Agapi Karkabouna, Athina A Samara, Konstantina Zacharouli, Maria Ioannou, Antonios Garas, Alexandros Daponte, Sotirios Sotiriou

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agapi KarkabounaDepartment of Embryology, University of Thessaly, Larissa, Greece.
Athina A SamaraDepartment of Embryology, University of Thessaly, Larissa, Greece; athsamara@uth.gr.
Konstantina ZacharouliDepartment of Pathology, University of Thessaly, Larissa, Greece.
Maria IoannouDepartment of Pathology, University of Thessaly, Larissa, Greece.
Antonios GarasDepartment of Obstetrics Gynecology, University Hospital of Larissa, Larissa, Greece.
Alexandros DaponteDepartment of Obstetrics Gynecology, University Hospital of Larissa, Larissa, Greece.
Sotirios SotiriouDepartment of Embryology, University of Thessaly, Larissa, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimFetal growth restriction (FGR) is a major and common complication of pregnancy. As the placenta holds the key to fetal growth, the detection of biomarkers associated with FGR is essential. The aim of the present study was to compare the expression of MATERIALS AND

methodsPostpartum samples from chorionic villi from pregnancies were used for the present study. An immunochemical pathology study was performed in order to study the expression of O-GlcNAc epitope H.

resultsIn total, 30 pregnant women were included. When the expression of epitope H between the two groups was compared, the proportion of FGR pregnancies with high expression of epitope H in chorionic villi was statistically significant higher (

conclusionAlthough preliminary findings regarding the expression of O-GlcNAc epitope H in chorionic villi samples of pregnancies complicated by FGR are promising, further studies are expected to contribute to a better understanding of the role of O-GlcNacylation in FGR pathogenesis and its clinical significance.

Indexed as

AcetylglucosamineEpitopesFetal Growth RetardationPlacentaAdultBiomarkersCase-Control StudiesChorionic VilliFemaleHumansImmunohistochemistryPregnancyAcetylglucosamineBiomarkersEpitopesEpitope HFGRimmunochemistryO-GlcNacylationplacenta

Identifiers

PMID41167701
PMCPMC12588206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.